Go Pro

Arkema SA (OTCMKTS:ARKAY) Stock Short Interest Jumps 133.4%

Arkema logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Arkema’s short interest rose 133.4% to 1,858 shares as of September 15, up from 796 shares at the end of August. Despite the increase, short interest represented approximately 0.0% of shares outstanding, with a days-to-cover ratio of 0.8.
  • Analyst sentiment remained cautious, with one Buy rating, six Holds and one Sell; the consensus rating was Hold. Goldman Sachs downgraded the stock to Neutral, while Barclays upgraded it from Strong Sell to Hold.
  • Arkema shares opened at $64.50, near the lower end of their 12-month range of $56.28 to $79.36. In its latest quarter, the company beat earnings expectations with EPS of $1.98 versus $1.86 expected, but revenue of $2.79 billion came in below the $2.86 billion estimate.
  • MarketBeat previews top five stocks to own in October.

Arkema SA (OTCMKTS:ARKAY - Get Free Report) saw a large growth in short interest in the month of September. As of September 15th, there was short interest totaling 1,858 shares, a growth of 133.4% from the August 31st total of 796 shares. Based on an average trading volume of 2,376 shares, the days-to-cover ratio is currently 0.8 days. Approximately 0.0% of the shares of the company are sold short.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on ARKAY. The Goldman Sachs Group cut Arkema from a "buy" rating to a "neutral" rating in a research report on Monday, June 8th. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating on shares of Arkema in a research report on Tuesday, June 23rd. Finally, Barclays raised shares of Arkema from a "strong sell" rating to a "hold" rating in a report on Wednesday, August 12th. One analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Hold".

Get Our Latest Research Report on Arkema

Arkema Stock Down 0.1%

Shares of ARKAY opened at $64.50 on Friday. The company has a quick ratio of 1.08, a current ratio of 1.52 and a debt-to-equity ratio of 0.42. The company has a 50-day moving average price of $67.86 and a two-hundred day moving average price of $67.77. The stock has a market cap of $4.91 billion, a price-to-earnings ratio of 222.41 and a beta of 0.85. Arkema has a 12 month low of $56.28 and a 12 month high of $79.36.

Arkema (OTCMKTS:ARKAY - Get Free Report) last released its quarterly earnings data on Thursday, July 30th. The basic materials company reported $1.98 earnings per share for the quarter, beating the consensus estimate of $1.86 by $0.12. Arkema had a return on equity of 4.30% and a net margin of 0.67%.The company had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.86 billion. Equities analysts predict that Arkema will post 3.68 EPS for the current fiscal year.

About Arkema

(Get Free Report)

Arkema is a France-based specialty materials company that develops and manufactures high-performance materials for industrial and consumer applications. Its portfolio includes advanced polymers, adhesives, coating materials, specialty additives and other chemical products designed to improve durability, performance and sustainability.

The company serves industries such as automotive, construction, consumer goods, electronics, energy, packaging, sports and healthcare. Its products include specialty adhesives, acrylic and fluoropolymer materials, technical resins, coating solutions and materials used in lightweight, durable and lower-impact applications.

Arkema was established in 2004 following the reorganization of Total's chemicals businesses and has expanded into a global specialty materials group with operations and customers across Europe, North America, Asia and other international markets.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Arkema Right Now?

Before you consider Arkema, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arkema wasn't on the list.

While Arkema currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines